---
schema_version: "secwatch.filing_event.v1"
accession: "0001477449-24-000157"
form_type: "8-K"
ticker: "TDOC"
cik: "0001477449"
company_name: "Teladoc Health, Inc."
filed_at: "2024-06-10T23:59:59+00:00"
generated_at: "2026-06-01T05:16:40.770896+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Teladoc Health names Chuck Divita as CEO effective June 10, 2024

## Summary
- Charles Divita appointed CEO and board member; Mala Murthy returns to CFO role.
- Divita previously EVP Commercial Markets at GuideWell/Florida Blue, overseeing $23B in revenue.
- New-hire equity award valued at ~$15M: 939,849 PSUs and 469,924 RSUs; base salary $800,000.
- Company amended 2023 Inducement Plan, increasing reserved shares by 4M to 4.5M for CEO grants.
- Mala Murthy's severance agreement amended to provide two years of enhanced severance protections.

## SEC filing metadata
- accession: 0001477449-24-000157
- form_type: 8-K
- ticker: TDOC
- cik: 0001477449
- company_name: Teladoc Health, Inc.
- filed_at: 2024-06-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1477449/000147744924000157/0001477449-24-000157-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1477449/000147744924000157/tdoc-20240605.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477449-24-000157
- JSON: https://secwatch.observer/filing/0001477449-24-000157.json
- Plain text: https://secwatch.observer/filing/0001477449-24-000157.txt

## Key facts
- Executive change
  Charles Divita, III was appointed as Director at Teladoc Health, Inc..
  - Action: appointed
  - Role: Director
  source text: appointed Mr. Divita as a director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1477449/000147744924000157/0001477449-24-000157-index.htm
- Executive change
  Charles Divita, III was appointed as Chief Executive Officer at Teladoc Health, Inc..
  - Action: joined
  - Role: Chief Executive Officer
  source text: Charles Divita, III joined Teladoc Health, Inc. (the “Company”) as its Chief Executive Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1477449/000147744924000157/0001477449-24-000157-index.htm
- Executive change
  Mala Murthy changed role as Chief Financial Officer at Teladoc Health, Inc..
  - Action: stepped down as acting Chief Executive Officer
  - Role: Chief Financial Officer
  source text: Mala Murthy stepped down as acting Chief Executive Officer of the Company and will remain the Company's Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1477449/000147744924000157/0001477449-24-000157-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.